会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Highly sensitive method for the detection of cytosine methylation patterns
    • 用于检测胞嘧啶甲基化模式的高灵敏度方法
    • US07229759B2
    • 2007-06-12
    • US10229370
    • 2002-08-27
    • Alexander OlekKurt Berlin
    • Alexander OlekKurt Berlin
    • C12Q1/68C12N15/11
    • C12Q1/6827C12Q2523/125C12Q2537/163
    • The present invention concerns a method for the detection of cytosine methylation in DNA samples, wherein the following steps are conducted: (a) a genomic DNA sample, which comprises the DNA to be investigated and background DNA, is chemically treated in such a way that all of the unmethylated cytosine bases are converted to uracil, whereas the 5-methylcytosine bases remain unchanged; (b) the chemically treated DNA sample is amplified with the use of at least 1 primer oligonucleotide as well as a polymerase, whereby the DNA to be investigated is preferred as the template over the background DNA, and (c) the amplified products are analyzed and the methylation status in the DNA to be investigated is concluded from the presence of an amplified product and/or from the analysis of additional positions.
    • 本发明涉及检测DNA样品中胞嘧啶甲基化的方法,其中进行以下步骤:(a)将包含待研究的DNA和背景DNA的基因组DNA样品进行化学处理,使其 所有未甲基化的胞嘧啶碱基被转化成尿嘧啶,而5-甲基胞嘧啶碱基保持不变; (b)使用至少1种引物寡核苷酸和聚合酶扩增化学处理的DNA样品,由此优选待研究的DNA作为背景DNA上的模板,(c)分析扩增产物 并且待研究的DNA中的甲基化状态从扩增产物的存在和/或从额外位置的分析得出。
    • 10. 发明申请
    • Method and device for determination of tissue specificity of free floating dna in bodily fluids
    • 用于测定体液中游离氨基酸的组织特异性的方法和装置
    • US20050221314A1
    • 2005-10-06
    • US10506693
    • 2003-03-05
    • Kurt BerlinAndrzej Sledziewski
    • Kurt BerlinAndrzej Sledziewski
    • G01N33/50C12N15/09C12N15/10C12Q1/68G01N21/78G01N33/53G01N33/566
    • C12N15/1003C12Q1/6806C12Q2600/156
    • The present invention relates to methods for detecting free floating nucleic acids, as present in not cellular bound nucleic acids in bodily fluids like plasma or serum fractions of human or animal blood or in any other tissue samples derived from the human or animal body in order to diagnose a cell proliferative disease. Specifically the invention relates to the detection of increased levels of nucleic acids in bodily fluids. Furthermore the invention allows to determine the source of the enriched DNA by measuring the ratio of DNA originating from a certain organ versus total DNA from other organs in a given bodily fluid sample by specifying the DNA's methylation pattern. This can be done with or without increasing the DNA concentration of a given biological sample. In a preferred embodiment a further analysis of this methylation pattern allows for the detection of the presence of tumourous or otherwise proliferative disease in said organ.
    • 本发明涉及用于检测游离漂浮核酸的方法,其存在于体液中的非细胞结合核酸中,如人或动物血液的血浆或血清部分或源自人或动物体的任何其他组织样品,以便 诊断细胞增殖性疾病。 具体地,本发明涉及检测体液中核酸的增加水平。 此外,本发明允许通过指定DNA的甲基化模式,通过测量来自特定器官的DNA与给定体液样品中来自其他器官的总DNA的比例来确定富集DNA的来源。 这可以在或不增加给定生物样品的DNA浓度的情况下进行。 在优选的实施方案中,该甲基化模式的进一步分析允许检测所述器官中肿瘤或其他增殖性疾病的存在。